€4.50
(1.39%)
0.71%
Create an alert
Stocks and Shares ISAVirbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.
Company Information
About this company
Key people
Marie-Helene Dick-Madelpuech
Member of the Supervisory Board - Representative of Investec
Philippe Gaston Henri Capron
Independent Member of the Supervisory Board
Solene Madelpuech
Non-Executive Member of the Board of Directors
Luc Thielland
Non-Executive Director, Employee Representative
Paul Martingell
Chief Executive Officer, Member of the Executive Board and Group Executive Committee
Habib Ramdani
Deputy Chief Executive Officer, Chief Financial Officer, Member of the Executive Board and Group Executive Committee
Pierre Madelpuech
Vice Chairman of the Supervisory Board
Francesca Cortella
Head - Corporate Human Resources, Member of the Group Executive Committee
Sophie Favini
Head - Global Business Operations, Member of the Group Executive Committee
Bertrand Havrileck
Head - Corporate Research and Development, Member of the Group Executive Committee
Andre Mathieu
Director - Global Industrial Operations, Supply Chain and Sourcing, Member of the Group Executive Committee
Nathalie Pollet
Head - Global Marketing and Market Development, Member of the Group Executive Committee
Click to see more
Key facts
- Shares in issue8.39m
- EPICVIRP
- ISINFR0000031577
- LocationFrance
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€2.75bn
- Employees6,442
- ExchangeEuronext Paris
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.